S 4327In Committee
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Introduced April 16, 2026
Summary
Timeline
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact